MENU
AEON
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AEON Biopharma (AEON) Ownership - Who owns AEON Biopharma?
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market... Show more
Profile
Industry
N/A
Address
5 Park Plaza
Phone
+1 949 354-6499
Employees
10
Web
https://www.aeonbiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
833.03K
P/E Ratio
N/A
Total Cash
16.18M
Projected Growth
N/A
Total Debt
16.5M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
14.56
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AEON
Capitalization
833K
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
16.2M
Total Cash/Share
14.56
Total Debt
16.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-32.09M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-172.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
0.22
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-48.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-610.62
Shares Held By Institutions
N/A
Shares Outstanding - Current
1.11M
Total Liabilities
36.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-98.071
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5 Park Plaza
Phone
+1 949 354-6499
Employees
10
Web
https://www.aeonbiopharma.com